Unlock instant, AI-driven research and patent intelligence for your innovation.

Viral obesity methods and compositions

a composition and obesity technology, applied in the field of obesity in humans, can solve the problems of poor self-image, poor body image, social problems of obese people, etc., and achieve the effect of lowering tg, chol and ldl-chol levels

Inactive Publication Date: 2007-04-03
OBETECH LLC
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0020]Further we have discovered that humans who suffer from viral obesity (i.e., obesity caused by a virus) have, on the average, significantly lower TG, CHOL and LDL-CHOL levels than pe

Problems solved by technology

Obesity, in people who have the disease, is associated with physical, psychological, and social problems.
Psychological complications of obesity include poor self-image and poor body-image.
These complications are due in part to the fact that obesity is socially disfavored.
The fact that obesity is socially disfavored also presents social problems for obese people.
Among these is discrimination in jobs, education and marriage.
However, there has been no convincing evidence to support this speculation.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0058]Serum cholesterol (total)(TG) is determined using fasting serum, 10 microliter samples, in a cholesterol-oxidase-peroxidase method employing a kit from Sigma Chemical Co., St. Louis, Mo., USA (Cat. No. 352-SOOP).

[0059]Serum triglyceride (TG) is determined using fasting serum, 10 microliter samples, in a glycerol-3-phosphate peroxidase method employing a kit from Sigma Chemical Co. (Cat. No. 339-50).

[0060]Serum high-density-lipoprotein-associated cholesterol (HDL-CHOL) is determined using fasting serum with a kit from Sigma Chemical Co.

[0061]Low-density-lipoprotein-associated cholesterol (LDL-CHOL) is determined using the equation

LDL-CHOL=(CHOL)−(HDL-CHOL)−(TG / 5).

example 2

[0062]Ad-36 virus was obtained from the ATCC (American Type Culture Collection), Accession No. VR-913. The virus was grown in A549 bronchial human carcinoma cells (Wisconsin State Laboratory of Hygiene, University of Wisconsin, Madison, Wis., USA). Plaques were grown, and a single plaque was removed and used to reinfect a fresh batch of A549 cells. Plaques of this second passage were grown and again a single plaque was picked and used to reinfect another fresh batch of A549 cells. The resulting virus is Ad-36P.

[0063]In virus neutralization assays of 5 human sera known to have antibodies to Ad-36 (ATTC VR-913), Ad-36p showed a 2- to 4-fold greater titer for neutralizing antibodies than did Ad-36. This demonstrates the greater sensitivity of Ad-36p, as compared to Ad-36, in assaying serum for antibody against obesity-causing adenoviruses.

example 3

[0064]Minimum Essential Media Eagle (MEM)(Sigma Chemical Co. Cat. No. M-0643) with non-essential amino acids, Earle's salts, 1-glutamine, 10% fetal bovine serum and 2.9% sodium bicarbonate (v / v), pH 7.4, is used for growing A549 cells. 5 to 10 microliters of virus stock solution is mixed with 8 ml of the medium and the mixture is pipetted into flasks with growing cells. The flasks are incubated for 1 h at 37 deg. C. while shaking gently every 15 min. After 1 h, the medium is removed and replaced with fresh medium. The flasks are then incubated at 37 deg. C. The cells are grown over 7 to 8 days, until 90% of the cells show CPE. The cell material and medium are then centrifuged at 1000 rpm for 15 min to eliminate cell debris. The supernatant with virus (e.g., Ad-36 or Ad-36P), is again centrifuged at 1000 rpm for 10 min and then aliquoted into 2 ml cryovials for storage at −70 deg. C. until use.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Body mass indexaaaaaaaaaa
Login to View More

Abstract

A source of viral induced obesity has been discovered. A virus known as AD-36Padenovirus type 36 has been found to be associated with obesity in both animals and humans. Diagnostic DNA sequences are presented so that DNA based tests for the presence of the obesity associated virus can be conducted.

Description

RELATED APPLICATION[0001]This application is a continuation of patent application Ser. No. 09 / 056,153 filed Apr. 6, 1998, now U.S. Pat. No. 6,127,113, which claims the benefit of the provisional U.S. application Ser. No. 60 / 042,942 filed Apr. 4, 1997.TECHNICAL FIELD[0002]This invention concerns obesity in humans caused by viruses and methods and compositions for diagnosing, treating and preventing this disease.[0003]The invention also concerns methods and compositions for reducing levels of triglycerides and cholesterol in humans.[0004]More particularly, the invention concerns methods and compositions for diagnosing whether obesity in a human is caused by a virus or whether a person is susceptible to becoming obese because of having been infected with andan obesity-causing virus, methods for testing or screening body fluids (e.g., donated human blood) for the presence of obesity-causing viruses, methods for treating and preventing viral obesity in humans, methods for preparing vacci...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/68A61K39/00A61K39/235C07K14/075C12N7/00C12Q1/6883C12Q1/70G01N33/569
CPCA61K39/00A61K39/235C07K14/005C07K16/081C07K2317/76C12N7/00C12N2710/10321C12N2710/10322C12N2710/10334C12Q1/6883C12Q1/701G01N33/56983G01N2333/075G01N2800/044A61K39/12
Inventor ATKINSON, RICHARD L.DHURANDHAR, NIKHIL V.
Owner OBETECH LLC